{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-015061","form_type":"8-K","ticker":null,"cik":"0000793171","company_name":"Vitro Biopharma, Inc.","filed_at":"2024-04-17T23:59:59+00:00","discovered_at":"2026-05-14T18:03:21.989992+00:00","generated_at":"2026-06-03T21:58:25.334564+00:00","sec_items":["1.01","2.03","3.02","9.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Vitro BioPharma issues $218,750 senior secured convertible note at 20% OID, with warrants","bullets":["Principal amount $218,750; purchase price $175,000 (20% original issue discount).","Interest accrues at 20% annual rate from earlier of maturity or Event of Default; payable monthly.","Maturity date May 16, 2024, extendable to August 16, 2024 at Company's option.","Convertible into common stock at 70% (or 60% if extended) of Liquidity Event Price (IPO/Direct Listing).","Warrants exercisable for 5 years; exercise price based on Liquidity Event Price or $95M valuation."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-015061","json":"https://secwatch.observer/filing/0001493152-24-015061.json","markdown":"https://secwatch.observer/filing/0001493152-24-015061.md","text":"https://secwatch.observer/filing/0001493152-24-015061.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/793171/000149315224015061/0001493152-24-015061-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/793171/000149315224015061/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-03T21:58:25.334564+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"00107ce63d55c2b1e7a54e67e5220a6c877adbba","claim":"Vitro Biopharma, Inc. incurred convertible notes of $218,750 with an accredited investor at 20% maturing the earlier of (i) May 16, 2024, and (ii) the occurrence of a Liquidity Event.","evidence_excerpt":"On April 11, 2024, Vitro BioPharma, Inc. (the “Company”) issued and sold to an accredited investor, in a private placement, (i) a senior secured convertible note (the “Note”) in the principal amount of $218,750, for a purchase price of $175,000 (reflecting a 20% original issue discount), and warrants to purchase shares of common stock of the Company (the “Warrants”), pursuant to a previously disclosed securities purchase agreement, dated November 16, 2023.","evidence_source":"SEC 8-K Item 2.03/2.04","evidence_url":"https://www.sec.gov/Archives/edgar/data/793171/000149315224015061/0001493152-24-015061-index.htm","confidence":0.9,"family_label":"Debt Financings","details":[{"label":"Instrument","value":"convertible notes"},{"label":"Principal","value":"$218,750"},{"label":"Counterparty","value":"an accredited investor"},{"label":"Rate","value":"20%"},{"label":"Maturity","value":"the earlier of (i) May 16, 2024, and (ii) the occurrence of a Liquidity Event"},{"label":"Event","value":"incurrence"}],"fact_type":"debt_financing"},{"claim_id":"e32d5a593d943bea7f491b968dcca480687ac2a0","claim":"Vitro Biopharma, Inc. entered into securities purchase agreement with an accredited investor (effective 2023-11-16).","evidence_excerpt":"(the “Company”) issued and sold to an accredited investor, in a private placement, (i) a senior secured convertible note (the “Note”) in the principal amount of $218,750, for a purchase price of $175,000","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/793171/000149315224015061/0001493152-24-015061-index.htm","confidence":0.4,"family_label":"Material Agreements","details":[{"label":"Agreement","value":"equity purchase"},{"label":"Counterparty","value":"an accredited investor"},{"label":"Effective","value":"2023-11-16"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}